Shandong Xinhua Pharmaceutical Company Limited (0719.HK)
HKD 5.6
(0.72%)
HKD 5.6
(0.72%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 1.35 Billion CNY | -1.82% |
| 2022 | 1.38 Billion CNY | 32.58% |
| 2021 | 1.04 Billion CNY | -4.03% |
| 2020 | 1.08 Billion CNY | -26.5% |
| 2019 | 1.47 Billion CNY | 8.46% |
| 2018 | 1.36 Billion CNY | 16.31% |
| 2017 | 1.17 Billion CNY | -13.43% |
| 2016 | 1.35 Billion CNY | -9.3% |
| 2015 | 1.49 Billion CNY | 1.28% |
| 2014 | 1.47 Billion CNY | 8.09% |
| 2013 | 1.36 Billion CNY | 12.67% |
| 2012 | 1.21 Billion CNY | 75.9% |
| 2011 | 688.46 Million CNY | 44.78% |
| 2010 | 475.52 Million CNY | 20.69% |
| 2009 | 394.02 Million CNY | 38.51% |
| 2008 | 284.47 Million CNY | 37.55% |
| 2007 | 206.81 Million CNY | -12.08% |
| 2006 | 235.23 Million CNY | -43.85% |
| 2005 | 418.96 Million CNY | -24.68% |
| 2004 | 556.28 Million CNY | 48.68% |
| 2003 | 374.15 Million CNY | 10.05% |
| 2002 | 340 Million CNY | 2.38% |
| 2001 | 332.1 Million CNY | 28.17% |
| 2000 | 259.1 Million CNY | -23.65% |
| 1999 | 339.37 Million CNY | 9.78% |
| 1998 | 309.12 Million CNY | 18.97% |
| 1997 | 259.84 Million CNY | -30.83% |
| 1996 | 375.64 Million CNY | 38.54% |
| 1995 | 271.15 Million CNY | 24.76% |
| 1994 | 217.34 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 1.31 Billion CNY | -3.17% |
| 2024 Q3 | 1.36 Billion CNY | -2.95% |
| 2024 Q2 | 1.4 Billion CNY | 6.59% |
| 2023 FY | 1.35 Billion CNY | -1.82% |
| 2023 Q1 | 1.33 Billion CNY | -3.36% |
| 2023 Q2 | 1.33 Billion CNY | -0.19% |
| 2023 Q4 | 1.35 Billion CNY | 0.18% |
| 2023 Q3 | 1.35 Billion CNY | 1.6% |
| 2022 FY | 1.38 Billion CNY | 32.58% |
| 2022 Q1 | 1.68 Billion CNY | 61.19% |
| 2022 Q4 | 1.38 Billion CNY | -26.2% |
| 2022 Q2 | 1.68 Billion CNY | -0.0% |
| 2022 Q3 | 1.87 Billion CNY | 11.47% |
| 2021 FY | 1.04 Billion CNY | -4.03% |
| 2021 Q1 | 1.11 Billion CNY | 2.92% |
| 2021 Q2 | 1.12 Billion CNY | 0.77% |
| 2021 Q3 | 1.1 Billion CNY | -2.24% |
| 2021 Q4 | 1.04 Billion CNY | -5.34% |
| 2020 Q4 | 1.08 Billion CNY | 3.48% |
| 2020 Q3 | 1.05 Billion CNY | -14.78% |
| 2020 Q2 | 1.23 Billion CNY | -17.73% |
| 2020 Q1 | 1.49 Billion CNY | 1.32% |
| 2020 FY | 1.08 Billion CNY | -26.5% |
| 2019 FY | 1.47 Billion CNY | 8.46% |
| 2019 Q1 | 1.34 Billion CNY | -1.78% |
| 2019 Q2 | 1.36 Billion CNY | 2.01% |
| 2019 Q3 | 1.44 Billion CNY | 5.37% |
| 2019 Q4 | 1.47 Billion CNY | 2.73% |
| 2018 Q2 | 1.28 Billion CNY | 3.58% |
| 2018 Q3 | 1.3 Billion CNY | 1.47% |
| 2018 FY | 1.36 Billion CNY | 16.31% |
| 2018 Q4 | 1.36 Billion CNY | 4.37% |
| 2018 Q1 | 1.24 Billion CNY | 6.03% |
| 2017 FY | 1.17 Billion CNY | -13.43% |
| 2017 Q4 | 1.17 Billion CNY | -16.88% |
| 2017 Q3 | 1.41 Billion CNY | -7.98% |
| 2017 Q2 | 1.53 Billion CNY | 9.01% |
| 2017 Q1 | 1.4 Billion CNY | 3.82% |
| 2016 FY | 1.35 Billion CNY | -9.3% |
| 2016 Q4 | 1.35 Billion CNY | -6.73% |
| 2016 Q1 | 1.49 Billion CNY | 0.02% |
| 2016 Q2 | 1.42 Billion CNY | -4.73% |
| 2016 Q3 | 1.45 Billion CNY | 2.06% |
| 2015 Q1 | 1.49 Billion CNY | 1.48% |
| 2015 Q4 | 1.49 Billion CNY | -4.85% |
| 2015 FY | 1.49 Billion CNY | 1.28% |
| 2015 Q3 | 1.56 Billion CNY | -1.95% |
| 2015 Q2 | 1.6 Billion CNY | 6.97% |
| 2014 Q1 | 1.27 Billion CNY | -6.27% |
| 2014 Q3 | 1.48 Billion CNY | 9.6% |
| 2014 Q4 | 1.47 Billion CNY | -0.74% |
| 2014 FY | 1.47 Billion CNY | 8.09% |
| 2014 Q2 | 1.35 Billion CNY | 6.0% |
| 2013 Q4 | 1.36 Billion CNY | 11.27% |
| 2013 FY | 1.36 Billion CNY | 12.67% |
| 2013 Q3 | 1.22 Billion CNY | 7.19% |
| 2013 Q2 | 1.14 Billion CNY | -16.37% |
| 2013 Q1 | 1.36 Billion CNY | 12.95% |
| 2012 FY | 1.21 Billion CNY | 75.9% |
| 2012 Q2 | 480.09 Million CNY | -18.36% |
| 2012 Q1 | 588.07 Million CNY | -14.58% |
| 2012 Q3 | 628.22 Million CNY | 30.85% |
| 2012 Q4 | 1.21 Billion CNY | 92.77% |
| 2011 Q2 | 594.94 Million CNY | 3.42% |
| 2011 FY | 688.46 Million CNY | 44.78% |
| 2011 Q4 | 688.46 Million CNY | -7.27% |
| 2011 Q3 | 742.46 Million CNY | 24.79% |
| 2011 Q1 | 575.26 Million CNY | 20.97% |
| 2010 Q2 | 443.61 Million CNY | 4.64% |
| 2010 Q3 | 493.17 Million CNY | 11.17% |
| 2010 Q4 | 475.52 Million CNY | -3.58% |
| 2010 Q1 | 423.96 Million CNY | 7.6% |
| 2010 FY | 475.52 Million CNY | 20.69% |
| 2009 Q2 | 339.06 Million CNY | 11.5% |
| 2009 FY | 394.02 Million CNY | 38.51% |
| 2009 Q3 | 354.13 Million CNY | 4.44% |
| 2009 Q1 | 304.1 Million CNY | 6.9% |
| 2009 Q4 | 394.02 Million CNY | 11.26% |
| 2008 Q2 | 245.14 Million CNY | 10.99% |
| 2008 FY | 284.47 Million CNY | 37.55% |
| 2008 Q1 | 220.87 Million CNY | 6.8% |
| 2008 Q4 | 284.47 Million CNY | -24.37% |
| 2008 Q3 | 376.14 Million CNY | 53.44% |
| 2007 FY | 206.81 Million CNY | -12.08% |
| 2007 Q3 | 102.89 Million CNY | -22.76% |
| 2007 Q1 | 234 Million CNY | -0.52% |
| 2007 Q2 | 133.2 Million CNY | -43.07% |
| 2007 Q4 | 206.81 Million CNY | 101.0% |
| 2006 Q2 | 352.22 Million CNY | -15.48% |
| 2006 Q1 | 416.71 Million CNY | -0.54% |
| 2006 Q4 | 235.23 Million CNY | -49.04% |
| 2006 FY | 235.23 Million CNY | -43.85% |
| 2006 Q3 | 461.6 Million CNY | 31.05% |
| 2005 Q2 | 650.81 Million CNY | 22.65% |
| 2005 Q4 | 418.96 Million CNY | -21.28% |
| 2005 Q3 | 532.2 Million CNY | -18.23% |
| 2005 Q1 | 530.61 Million CNY | -4.61% |
| 2005 FY | 418.96 Million CNY | -24.68% |
| 2004 Q4 | 556.28 Million CNY | 0.04% |
| 2004 Q1 | 475.14 Million CNY | 26.99% |
| 2004 Q3 | 556.08 Million CNY | -7.75% |
| 2004 FY | 556.28 Million CNY | 48.68% |
| 2004 Q2 | 602.8 Million CNY | 26.87% |
| 2003 FY | 374.15 Million CNY | 10.05% |
| 2003 Q1 | 330 Million CNY | -2.94% |
| 2003 Q2 | 330 Million CNY | 0.0% |
| 2003 Q3 | 402.77 Million CNY | 22.05% |
| 2003 Q4 | 374.15 Million CNY | -7.1% |
| 2002 Q3 | 330 Million CNY | 0.0% |
| 2002 Q1 | 317.1 Million CNY | -4.52% |
| 2002 FY | 340 Million CNY | 2.38% |
| 2002 Q2 | 330 Million CNY | 4.07% |
| 2002 Q4 | 340 Million CNY | 3.03% |
| 2001 Q4 | 332.1 Million CNY | 0.0% |
| 2001 Q2 | 299.3 Million CNY | 0.0% |
| 2001 FY | 332.1 Million CNY | 28.17% |
| 2000 FY | 259.1 Million CNY | -23.65% |
| 2000 Q4 | 259.1 Million CNY | 0.0% |
| 2000 Q2 | 368.86 Million CNY | 0.0% |
| 1999 FY | 339.37 Million CNY | 9.78% |
| 1999 Q4 | 339.37 Million CNY | 0.0% |
| 1999 Q2 | 331.79 Million CNY | 0.0% |
| 1998 Q4 | 309.12 Million CNY | 0.0% |
| 1998 FY | 309.12 Million CNY | 18.97% |
| 1998 Q2 | 287.8 Million CNY | 0.0% |
| 1997 Q4 | 259.84 Million CNY | 0.0% |
| 1997 FY | 259.84 Million CNY | -30.83% |
| 1997 Q2 | - CNY | 0.0% |
| 1996 FY | 375.64 Million CNY | 38.54% |
| 1996 Q4 | 375.64 Million CNY | 0.0% |
| 1995 FY | 271.15 Million CNY | 24.76% |
| 1994 FY | 217.34 Million CNY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 6.8 Million HKD | -19851.437% |
| Grand Pharmaceutical Group Limited | 3.4 Billion HKD | 60.088% |
| Extrawell Pharmaceutical Holdings Limited | 120.41 Million HKD | -1028.389% |
| Wai Yuen Tong Medicine Holdings Limited | 460.94 Million HKD | -194.76% |
| Qianhai Health Holdings Limited | 487 Thousand HKD | -278892.331% |
| Lee's Pharmaceutical Holdings Limited | 204.14 Million HKD | -565.569% |
| Essex Bio-Technology Limited | 294.02 Million HKD | -362.105% |
| Tongfang Kontafarma Holdings Limited | 333.82 Million HKD | -307.01% |
| PuraPharm Corporation Limited | 424.77 Million HKD | -219.865% |
| SSY Group Limited | 3.37 Billion HKD | 59.732% |
| JBM (Healthcare) Limited | 133.4 Million HKD | -918.457% |
| Jacobson Pharma Corporation Limited | 749.37 Million HKD | -81.309% |
| China Resources Pharmaceutical Group Limited | 85.84 Billion HKD | 98.417% |